The IAS–USA programs – such as conferences, Web-based CME publications, and practice guidelines – are offered as part of a nationwide effort to inform health care practitioners about the evolving challenges of caring for patients with viral infections.
Hepatitis C patients taking part in these open CME programs will acquire new knowledge about either HCV drugs undergoing clinical trials or those currently in clinical practice.
CME Webcast
Beyond Telaprevir and Boceprevir: Resistance and New Agents for HCV Infection
Presenter(s): David L Wyles MD
Airdate: July 27, 2012
Topics
Discusses resistance and new agents for HCV Infection including interferon free regimens
Instructions
1-Watch the Webcast
2-Scroll to the bottom of the page to confirm you have read and understand the instructions.
Presenter(s): Kenneth E Sherman MD, PhD
Airdate: June 07, 2012
Instructions
1-Watch the Webcast
2-Scroll to the bottom of the page to confirm you have read and understand the instructions.
HCV Drug Interactions: Trials, Tribulations, and Downright Confusion: A Case-Based Discussion
Presenter(s): Charles W Flexner MD
Airdate: June 07, 2012
Instructions
1-Watch the Webcast
2-Scroll to the bottom of the page to confirm you have read and understand the instructions.
Managing End-Stage Liver Disease in HCV Patients: The Minimum You Need to Know: A Case-Based Panel Discussion
Presenter(s): Marion G Peters MD
Airdate: June 07, 2012
Instructions
1-Watch the Webcast
2-Scroll to the bottom of the page to confirm you have read and understand the instructions.
CME
Management of Chronic Hepatitis C Virus Infection in Advanced Liver Disease
Kenneth E. Sherman, MD, PhD, and Syed Hussain, MD
Release Date: July 27, 2012
Instructions
1-Click Here To Begin
2-Scroll to the bottom of the page to confirm you have read and understand the instructions.
3-Click Begin Activity
No comments:
Post a Comment